Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jillian M Richmond

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
F1000Research|November 4, 2020
Potential therapeutic manipulations of the CXCR3 chemokine axis for the treatment of inflammatory fibrosing diseasesMorgan K Groover, Jillian M Richmond
Cold Spring Harbor Perspectives in Medicine|December 3, 2014
Immunology and skin in health and diseaseJillian M Richmond, John E Harris
Current Research in Immunology|May 2, 2022
Immunopathogenesis of alopecia areataJadesola Jadé Temitope Olayinka, Jillian M Richmond
Research in Veterinary Science|April 19, 2026
Comparison of human and canine atopic dermatitis transcriptome: A meta-analysis and review from a one health perspectiveYu Wang, Jillian M Richmond, Ramon M Almela
Frontiers in Immunology|May 20, 2021
Resident Memory T Cells in Autoimmune Skin DiseasesGrace E Ryan, John E Harris, Jillian M Richmond
Expert Review of Clinical Immunology|February 25, 2022
Evaluating the use of JAK inhibitors in inflammatory connective tissue diseases in pediatric patients: an updateJane Chuprin, Lindsay McCormack, Jillian M Richmond, et al.
The Journal of Investigative Dermatology|April 20, 2024
IL-12/IL-23-Independent Function of BATF3-Dependent Dendritic Cells Is Required for Initiation of Disease in a Mouse Model of VitiligoMichael L Frisoli, Jillian M Richmond, John E Harris
Current Protocols in Immunology|September 26, 2018
Mouse Model for Human VitiligoRebecca L Riding, Jillian M Richmond, John E Harris
Current Opinion in Immunology|November 19, 2013
Innate immune mechanisms in vitiligo: danger from withinJillian M Richmond, Michael L Frisoli, John E Harris
Pigment Cell & Melanoma Research|October 11, 2020
Type I interferon signaling limits viral vector priming of CD8<sup>+</sup> T cells during initiation of vitiligo and melanoma immunotherapyRebecca L Riding, Jillian M Richmond, Keitaro Fukuda, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
F1000Research|November 4, 2020
Potential therapeutic manipulations of the CXCR3 chemokine axis for the treatment of inflammatory fibrosing diseasesMorgan K Groover, Jillian M Richmond
Cold Spring Harbor Perspectives in Medicine|December 3, 2014
Immunology and skin in health and diseaseJillian M Richmond, John E Harris
Current Research in Immunology|May 2, 2022
Immunopathogenesis of alopecia areataJadesola Jadé Temitope Olayinka, Jillian M Richmond
Research in Veterinary Science|April 19, 2026
Comparison of human and canine atopic dermatitis transcriptome: A meta-analysis and review from a one health perspectiveYu Wang, Jillian M Richmond, Ramon M Almela
Frontiers in Immunology|May 20, 2021
Resident Memory T Cells in Autoimmune Skin DiseasesGrace E Ryan, John E Harris, Jillian M Richmond
Expert Review of Clinical Immunology|February 25, 2022
Evaluating the use of JAK inhibitors in inflammatory connective tissue diseases in pediatric patients: an updateJane Chuprin, Lindsay McCormack, Jillian M Richmond, et al.
The Journal of Investigative Dermatology|April 20, 2024
IL-12/IL-23-Independent Function of BATF3-Dependent Dendritic Cells Is Required for Initiation of Disease in a Mouse Model of VitiligoMichael L Frisoli, Jillian M Richmond, John E Harris
Current Protocols in Immunology|September 26, 2018
Mouse Model for Human VitiligoRebecca L Riding, Jillian M Richmond, John E Harris
Current Opinion in Immunology|November 19, 2013
Innate immune mechanisms in vitiligo: danger from withinJillian M Richmond, Michael L Frisoli, John E Harris
Pigment Cell & Melanoma Research|October 11, 2020
Type I interferon signaling limits viral vector priming of CD8<sup>+</sup> T cells during initiation of vitiligo and melanoma immunotherapyRebecca L Riding, Jillian M Richmond, Keitaro Fukuda, et al.
Pageof 5